These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35368224)

  • 1. Short chain fatty acids for the risk of diabetic nephropathy in type 2 diabetes patients.
    Li Y; Qin GQ; Wang WY; Liu X; Gao XQ; Liu JH; Zheng T; Zhang W; Cheng L; Yang K; You X; Wu Y; Fang ZZ
    Acta Diabetol; 2022 Jul; 59(7):901-909. PubMed ID: 35368224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Short-Chain Fatty Acids and Non-Alcoholic Fatty Liver Disease Severity in Patients with Type 2 Diabetes Mellitus.
    Tsai HJ; Hung WC; Hung WW; Lee YJ; Chen YC; Lee CY; Tsai YC; Dai CY
    Nutrients; 2023 Mar; 15(7):. PubMed ID: 37049552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma phenylalanine and tyrosine and their interactions with diabetic nephropathy for risk of diabetic retinopathy in type 2 diabetes.
    Luo HH; Li J; Feng XF; Sun XY; Li J; Yang X; Fang ZZ
    BMJ Open Diabetes Res Care; 2020 Sep; 8(1):. PubMed ID: 32883686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Net portal appearance of volatile fatty acids in sheep intraruminally infused with mixtures of acetate, propionate, isobutyrate, butyrate, and valerate.
    Kristensen NB; Pierzynowski SG; Danfaer A
    J Anim Sci; 2000 May; 78(5):1372-9. PubMed ID: 10834594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of aromatic amino acids in pathogeneses of diabetic nephropathy in Chinese patients with type 2 diabetes.
    Zhang S; Li X; Luo H; Fang ZZ; Ai H
    J Diabetes Complications; 2020 Oct; 34(10):107667. PubMed ID: 32674925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of volatile fatty acids on propionate metabolism and gluconeogenesis in caprine hepatocytes.
    Aiello RJ; Armentano LE
    J Dairy Sci; 1987 Dec; 70(12):2504-10. PubMed ID: 3448105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Association Between Leucine and Diabetic Nephropathy in Different Gender: A Cross-Sectional Study in Chinese Patients With Type 2 Diabetes.
    Gao X; Hou R; Li X; Qiu XH; Luo HH; Liu SL; Fang ZZ
    Front Endocrinol (Lausanne); 2020; 11():619422. PubMed ID: 33633688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein origin of the volatile fatty acids isobutyrate and isovalerate in human stool.
    Zarling EJ; Ruchim MA
    J Lab Clin Med; 1987 May; 109(5):566-70. PubMed ID: 3572204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-Chain Fatty Acids Ameliorate Diabetic Nephropathy via GPR43-Mediated Inhibition of Oxidative Stress and NF-
    Huang W; Man Y; Gao C; Zhou L; Gu J; Xu H; Wan Q; Long Y; Chai L; Xu Y; Xu Y
    Oxid Med Cell Longev; 2020; 2020():4074832. PubMed ID: 32831998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isobutyrate as a precursor of n-butyrate in the biosynthesis of tylosine and fatty acids.
    Rezanka T; Reichelová J; Kopecký J
    FEMS Microbiol Lett; 1991 Nov; 68(1):33-6. PubMed ID: 1769552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cecal short-chain fatty acids in experimental rabbit mucoid enteropathy.
    Toofanian F; Hamar DW
    Am J Vet Res; 1986 Nov; 47(11):2423-5. PubMed ID: 3789505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of volatile fatty acids in the blood plasma of cattle before and after an infusion of propionate and butyrate].
    Eulitz-Meder C; Hartung J; Geldermann H
    Berl Munch Tierarztl Wochenschr; 1989 May; 102(5):145-8. PubMed ID: 2742572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Faecal biomarkers in type 1 diabetes with and without diabetic nephropathy.
    Winther SA; Mannerla MM; Frimodt-Møller M; Persson F; Hansen TW; Lehto M; Hörkkö S; Blaut M; Forsblom C; Groop PH; Rossing P
    Sci Rep; 2021 Jul; 11(1):15208. PubMed ID: 34312454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased lipoxygenase and decreased cytochrome P450s metabolites correlated with the incidence of diabetic nephropathy: Potential role of eicosanoids from metabolomics in type 2 diabetic patients.
    Peng L; Sun B; Liu Y; Huang J; Chen G; Zhang X; Chen C; Wang D; Wang G
    Clin Exp Pharmacol Physiol; 2021 May; 48(5):679-685. PubMed ID: 33605471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary approaches to stop hypertension, mediterranean dietary pattern, and diabetic nephropathy in women with type 2 diabetes: A case-control study.
    Jayedi A; Mirzaei K; Rashidy-Pour A; Yekaninejad MS; Zargar MS; Akbari Eidgahi MR
    Clin Nutr ESPEN; 2019 Oct; 33():164-170. PubMed ID: 31451255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monocyte-lymphocyte ratio is a valuable predictor for diabetic nephropathy in patients with type 2 diabetes.
    Huang Q; Wu H; Wo M; Ma J; Fei X; Song Y
    Medicine (Baltimore); 2020 May; 99(19):e20190. PubMed ID: 32384513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes of gut microbiota in diabetic nephropathy and its effect on the progression of kidney injury.
    Cai K; Ma Y; Cai F; Huang X; Xiao L; Zhong C; Ren P; Luo Q; Chen J; Han F
    Endocrine; 2022 May; 76(2):294-303. PubMed ID: 35246764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The clinicopathological characteristics of diabetic nephropathy and non-diabetic renal diseases in diabetic patients].
    Xu J; Hu XF; Huang W; Shen PY; Zhang W; Ren H; Li X; Wang WM; Chen N; Pan XX
    Zhonghua Nei Ke Za Zhi; 2017 Dec; 56(12):924-929. PubMed ID: 29202533
    [No Abstract]   [Full Text] [Related]  

  • 19. Association and interaction analyses of genetic variants in ADIPOQ, ENPP1, GHSR, PPARgamma and TCF7L2 genes for diabetic nephropathy in a Taiwanese population with type 2 diabetes.
    Wu LS; Hsieh CH; Pei D; Hung YJ; Kuo SW; Lin E
    Nephrol Dial Transplant; 2009 Nov; 24(11):3360-6. PubMed ID: 19506043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance of Streptomyces cinnamonensis to butyrate and isobutyrate: production and properties of a new anti-isobutyrate (AIB) factor.
    Pospísil S
    J Gen Microbiol; 1991 Sep; 137(9):2141-6. PubMed ID: 1748869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.